Aman Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.65 M
- Company Age 20 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.83 Cr
- Revenue Growth 45.87%
- Profit Growth 209.73%
- Ebitda -66.77%
- Net Worth 0.65%
- Total Assets 1.71%
About Aman Drugs
Aman Drugs Private Limited (ADPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 February 2005 and has a history of 20 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.65 M.
The company has closed loans amounting to ₹9.83 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Krishna Sachan, Pradip Sachan, Shalini Sachan, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233DL2005PTC133070
- Company No.
133070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aman Drugs?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Sachan  | Director | 16-Feb-2005 | Current |
| Pradip Sachan | Director | 16-Feb-2005 | Current |
| Shalini Sachan | Director | 16-Feb-2005 | Current |
| Savitri Devi | Director | 16-Feb-2005 | Current |
| Arun Sachan | Director | 08-Apr-2016 | Current |
Financial Performance of Aman Drugs.
Aman Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.87% increase. The company also saw a substantial improvement in profitability, with a 209.73% increase in profit. The company's net worth moved up by a moderate rise of 0.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aman Drugs?
In 2023, Aman Drugs had a promoter holding of 78.46% and a public holding of 21.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avenue Pharma Private LimitedKrishna Sachan, Pradip Sachan and 1 more are mutual person
- Docplus Technologies Private Limited
Krishna Sachan is a mutual person
- Psa Drugs Llp
Pradip Sachan and Shalini Sachan are mutual person
- Lunaris Pharma Private Limited
Pradip Sachan and Shalini Sachan are mutual person
- Aps Drugs Private Limited
Pradip Sachan and Shalini Sachan are mutual person
Charges (Loans)
₹0
₹98.30 M
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 9.80 Cr
- Others : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2016 | Others | ₹0.30 M | Satisfied |
| 21 May 2012 | Standard Chartered Bank | ₹6.50 Cr | Satisfied |
| 21 May 2012 | Standard Chartered Bank | ₹3.30 Cr | Satisfied |
How Many Employees Work at Aman Drugs?
Aman Drugs has a workforce of 4 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aman Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aman Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
